Tuberculosis control and the private health sector in Bolivia: A survey of pharmacies

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 11, 2004, Pages 1325-1329

  Lambert, Marie Laurence ^a   Delgado, R ^b   Michaux, G ^c   Volz, A ^d   Van Der Stuyft, P ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

^c Belgian Technical Cooperation   (Bolivia)

^d Chest Specialist Society   (Bolivia)

Author keywords

Bolivia; Pharmacies; Private health sector; Tuberculosis; Tuberculosis control

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

BOLIVIA; CLINICAL PHARMACY; DRUG MARKETING; HEALTH SURVEY; HUMAN; INCIDENCE; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH; REVIEW; TREATMENT INDICATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; BOLIVIA; COMMUNICABLE DISEASE CONTROL; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; DRUG PRESCRIPTIONS; ETHAMBUTOL; HUMANS; ISONIAZID; PHARMACIES; PRESCRIPTION FEES; PRIVATE SECTOR; PYRAZINAMIDE; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 10044258748     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. World Health Organization. Involving private practitioners in tuberculosis control: issues, interventions and emerging policy framework. WHO/CDS/TB/2001.285. Geneva, Switzerland: WHO, 2001.
2. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001; 358: 912-916.
3. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb.) 2003; 83(1-3): 156-164.
4. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis 1998; 2: 324-329.
5. Rajeswari R, Balasubramanian R, Bose M S, Sekar L, Rahman F. Private pharmacies in tuberculosis control - a neglected link. Int J Tuberc Lung Dis 2002; 6: 171-173.
6. Marsh D, Hashim R, Hassany F, et al. Front-line management of pulmonary tuberculosis: an analysis of tuberculosis and treatment practices in urban Sindh, Pakistan. Tubercle Lung Dis 1996; 77: 86-92.
7. Lonnroth K, Lambregts K, Nhien D T, Quy H T, Diwan V K. Private pharmacies and tuberculosis control: a survey of case detection skills and reported anti-tuberculosis drug dispensing in private pharmacies in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2000; 4: 1052-1059.
8. Olle-Goig J E, Cullity J E, Vargas R. A survey of prescribing patterns for tuberculosis treatment amongst doctors in a Bolivian city. Int J Tuberc Lung Dis 1999; 3: 74-78.
9. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO report 2003. WHO/CDS/TB/2003.316. Geneva, Switzerland: WHO, 2003.
10. Estudio de la Prevalencia y Riesgo Anual de Infección Tuberculosa en las Escuelas Primerias de Bolivia 1999-2000. Ministerio de Salud y Previsión Social. Dirección General de Salud. Republica de Bolivia (Research report by Myrtha del Granado, 2001).
11. Programa Nacional de Control de la Tuberculosis. Manual de Normas Technicas. Ministerio de Salud y Previsión Social. Dirección General de Salud. Republica de Bolivia; 1999.
12. Ley del medicamento. Ley nr 1737 de 17 de Diciembre 1996. Gaceta Oficial de Bolivia 1996 (1965).
13. Hurtig A K, Pande S B, Baral S C, Porter J D, Bam D S. Anti-tuberculosis treatment in private pharmacies, Kathmandu Valley, Nepal. Int J Tuberc Lung Dis 2000; 4: 730-736.
14. Delgado R. The role of the private sector in TB control: the experience in Cochabamba, Bolivia. Thesis for Master of Science in Diseases Control. Antwerp, Belgium: Institute for Tropical Medicine, 2002.
15. Madden J M, Quick J D, Ross-Degnan D, Kafle K K. Undercover careseekers: simulated clients in the study of health provider behavior in developing countries. Soc Sci Med 1997; 45: 1465-1482.